Transaction #23819 · Form 4 · 0001104659-25-123596
Kyverna Therapeutics, Inc. · Purchase · Common Stock
Kyverna Therapeutics, Inc. · Transacted December 18, 2025 · Filed December 22, 2025
What does this filing report?
An SEC Form 4 filing for Kyverna Therapeutics, Inc. records a purchase involving Common Stock on December 18, 2025. The reported quantity was 133,333. The filing date is December 22, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Kyverna Therapeutics, Inc.
- Company CIK
- 0001994702
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 133,333
- Reported price
- 7.5
- Reference value
- 999,997.5
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 869,317
- Ownership description
- See Footnote
- SEC acceptance time
- Dec 22, 2025, 11:42 AM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Westlake BioPartners Fund I, L.P. ↗
10% owner
CIK 0001749591
- Westlake BioPartners Opportunity GP I, LLC ↗
10% owner
CIK 0001811945
- Westlake BioPartners Opportunity Fund I, L.P. ↗
10% owner
CIK 0001811946
- Westlake BioPartners GP I, LLC ↗
10% owner
CIK 0002007650
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Shares held directly by Westlake BioPartners Opportunity Fund I, L.P. ("Westlake Opportunity"). The general partner of Westlake Opportunity is Westlake BioPartners Opportunity GP I, LLC ("Westlake Opportunity GP I"). The voting and dispositive control over Westlake Opportunity GP I is held by the managing director of Westlake Opportunity GP I, Beth Seidenberg, and whom disclaims beneficial ownership of the shares held by Westlake Opportunity except to the extent of such person's pecuniary interest therein, if any. Sean Harper, a Reporting Person on Westlake Opportunity's prior Section 16 filings with respect to the Issuer, is no longer a managing director of Westlake Opportunity GP I, and accordingly, is not a Reporting Person on this Form 4.
- F2
- Shares held directly by Westlake BioPartners Fund I, L.P. ("Westlake I"). The general partner of Westlake I is Westlake BioPartners GP I, LLC ("Westlake GP I"). The voting and dispositive control over Westlake GP I is held by the managing director of Westlake GP I, Beth Seidenberg, and whom disclaims beneficial ownership of the shares held by Westlake I except to the extent of such person's pecuniary interest therein, if any. Sean Harper, a Reporting Person on Westlake I's prior Section 16 filings with respect to the Issuer, is no longer a managing director of Westlake GP I, and accordingly, is not a Reporting Person on this Form 4.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.